» Articles » PMID: 35072019

The Global Burden of Hospitalisation Due to Pneumonia Caused by in the Under-5 Years Children: A Systematic Review and Meta-analysis

Overview
Specialty General Medicine
Date 2022 Jan 24
PMID 35072019
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Pneumonia is a leading cause of childhood morbidity and mortality. This study aimed to estimate the global hospitalisation due to pneumonia in under-5 children.

Methods: We conducted a systematic review and meta-analysis of primary studies following the PRISMA-P guidelines. We searched Medline, Embase, Global Health, CINAHL, Global Index Medicus, Scopus, China National Knowledge Infrastructure, Wanfang, and CQvip. We included studies reporting data on pneumonia, confirmed by detection of the pathogen in sterile-site samples in under-5 hospitalised children, published in English or Chinese language and conducted between 1st January 1990 and 4th November 2021 and between 1st January 1990 and 30th September 2020, respectively. We excluded those testing upper respiratory tract samples and not reporting data on samples with other bacteria or absence of bacteria. We screened papers against pre-specified criteria, extracted data and assessed the bacteriological quality, and combined epidemiological and microbiological quality of studies using two self-designed checklists. Pooled proportions of hospitalisation episodes for pneumonia amongst all-cause pneumonia and the 95% confidence intervals were calculated using the random-effects model. The review protocol was registered on PROSPERO (CRD42021236606).

Findings: Of 26,218 studies identified, thirty-five studies enroling 20,708 hospitalised pneumonia episodes were included. Out of the total hospitalised pneumonia cases in this population, the pooled proportion of Staphylococcal pneumonia cases was 3% (95% CI 2% to 4%; I=96%). amongst 12 studies with higher microbiological quality, the pooled estimate was 6% (95% CI 2% to 10%; I= 98%). Based on the recent global estimates of hospitalised pneumonia in this age group, the 3% and 6% estimates represent 738 thousand and 1.48 million hospitalisations in 2019, respectively. Based on the Grading of Recommendations Assessment, Development, and Evaluation (GRADE), the overall quality of evidence was considered to be moderate.

Interpretation: Our findings are probably an underestimate because of the unknown and the likely limited sensitivity of current testing methods for Staphylococcal pneumonia diagnosis and widespread reported use of antibiotics before recruitment (in 46% of cases). is an important cause of hospitalisation for pneumonia in young children globally.

Funding: Bill and Melinda Gates Foundation (OPP 1,172,551) through a prime award to John Hopkins University.

Citing Articles

Early detection of bacterial pneumonia by characteristic induced odor signatures.

Arnold K, Gomez-Mejia A, de Figueiredo M, Boccard J, Singh K, Rudaz S BMC Infect Dis. 2024; 24(1):1467.

PMID: 39731069 PMC: 11681641. DOI: 10.1186/s12879-024-10371-7.


Analysis of the potentially pathogenic bacteria of lower respiratory tract infections in children per-, during and post-COVID-19: a retrospective study.

Xu X, Meng L, Li J, Zhang Y, Liu B, Jiang W Eur J Clin Microbiol Infect Dis. 2024; 44(1):167-180.

PMID: 39556174 DOI: 10.1007/s10096-024-04991-9.


Global burden associated with 85 pathogens in 2019: a systematic analysis for the Global Burden of Disease Study 2019.

Lancet Infect Dis. 2024; 24(8):868-895.

PMID: 38640940 PMC: 11269650. DOI: 10.1016/S1473-3099(24)00158-0.


epidemiology, pathophysiology, clinical manifestations and application of nano-therapeutics as a promising approach to combat methicillin resistant .

Bashabsheh R, Al-Fawares O, Natsheh I, Bdeir R, Al-Khreshieh R, Bashabsheh H Pathog Glob Health. 2023; 118(3):209-231.

PMID: 38006316 PMC: 11221481. DOI: 10.1080/20477724.2023.2285187.


FOXA2 attenuates lipopolysaccharide‑induced pneumonia by inhibiting the inflammatory response, oxidative stress and apoptosis through blocking of p38/STAT3 signaling.

Xue Z, Li Y, Xiao S, Zhang H, Xu J Exp Ther Med. 2023; 26(4):469.

PMID: 37664675 PMC: 10469380. DOI: 10.3892/etm.2023.12168.


References
1.
Ekalaksananan T, Pientong C, Kongyingyoes B, Pairojkul S, Teeratakulpisarn J, Heng S . Etiology of acute lower respiratory tract infection in children at Srinagarind Hospital, Khon Kaen, Thailand. Southeast Asian J Trop Med Public Health. 2002; 32(3):513-9. View

2.
Benet T, Picot V, Messaoudi M, Chou M, Eap T, Wang J . Microorganisms Associated With Pneumonia in Children <5 Years of Age in Developing and Emerging Countries: The GABRIEL Pneumonia Multicenter, Prospective, Case-Control Study. Clin Infect Dis. 2017; 65(4):604-612. PMC: 7108107. DOI: 10.1093/cid/cix378. View

3.
Nathan A, Teh C, Abdul Jabar K, Teoh B, Tangaperumal A, Westerhout C . Bacterial pneumonia and its associated factors in children from a developing country: A prospective cohort study. PLoS One. 2020; 15(2):e0228056. PMC: 7021284. DOI: 10.1371/journal.pone.0228056. View

4.
McAllister D, Liu L, Shi T, Chu Y, Reed C, Burrows J . Global, regional, and national estimates of pneumonia morbidity and mortality in children younger than 5 years between 2000 and 2015: a systematic analysis. Lancet Glob Health. 2018; 7(1):e47-e57. PMC: 6293057. DOI: 10.1016/S2214-109X(18)30408-X. View

5.
Bautista-Marquez A, Richardson V, Ortiz-Orozco O, Luna-Cruz M, Carnalla-Barajas M, Echaniz-Aviles G . Prevalence of pneumococcal disease, serotype distribution, and antimicrobial susceptibility in Mexican children younger than 5 years of age. Arch Med Res. 2013; 44(2):142-50. DOI: 10.1016/j.arcmed.2012.12.005. View